Clinical Care

About Clinical Care

California’s hospitals are dedicated to providing high-quality, safe, and person-centered health care. This wouldn’t be possible without the clinical services hospitals provide, which include emergency care, surgery, X-ray/radiology, laboratory services, and behavioral health care. The care that hospitals provide is shaped by their communities’ needs.

HQI Quality Quarterly Spotlights Patient Safety Strategies

What’s happening: The latest edition of Quality Quarterly explores the prevalence of behavioral health conditions among California hospital encounters, the dangers of menopause misdiagnosis, new patient safety measures outlined by the Centers for Medicare & Medicaid Services (CMS), and the need for effective reporting of workplace violence incidents by hospital staff.    

What else to know: More than half of California hospitals now use HQI’s Hospital Quality Improvement Platform (HQIP), which provides comparative analytics to help hospitals identify opportunities for improvement.  Learn about HQIP’s new features and updates in this latest edition. 

IV Solution Shortage Resources

CHA has compiled the following federal, state, and local resources to assist hospitals in navigating the current IV solution shortage:

State

  • California Board of Pharmacy | Temporary Provisions for Compounding Certain Parenteral Drug Products | October 16, 2024
  • California Department of Public Health | All-Facilities Letter 24-24: Intravenous (IV) Solution Shortage due to Hurricane Helene | October 9, 2024
  • Federal

  • U.S. Department of Health and Human Services | Fact Sheet: HHS Continues Taking Action to Increase Access and Supply of IV Fluids Following Hurricane Helene | October 18, 2024
  • Centers for Disease Control and Prevention | Health Advisory 518: Disruptions in Availability of Peritoneal Dialysis and Intravenous Solutions from Baxter International Facility in North Carolina | October 12, 2024
  • U.S. Department of Health and Human Services | Fact Sheet: Biden-Harris Administration Takes Action to Ensure Americans Can Access Medical Supplies Following Hurricanes Helene and Milton | October 11, 2024
  • U.S. Department of Health and Human Services | Letter to Health Care Leaders and Stakeholders on Impacts of Hurricane Helene from Secretary Becerra | October 9, 2024
  • American Hospital Association | Letter to Biden Administration Urging Action to Address IV Solution Supply Shortage | October 7, 2024
  • American Hospital Association | Special Bulletin: HHS, Baxter Announce Additional Mitigation Efforts to Increase Access, Supply of IV Fluids | October 18, 2024
  • American Hospital Association | Special Bulletin: Baxter Provides Updates on Efforts to Increase Access to and Supply of IV Solutions | October 24, 2024
  • American Hospital Association | Special Bulletin: Baxter Announces Expiration Dating Extensions for Certain Products Related to IV Solutions Disruption | October 28, 2024
  • Clinical Guidance

  • Food & Drug Administration | Temporary Policies for Compounding Certain Parenteral Drug Products | October 11, 2024
  • Baxter | Recommendations for Management and Conservation Measures & List of Impacted Supplies
  • Vizient | Product Disruption Brief | October 10, 2024
  • Vizient | Adult/Pediatric IV Push Medication Reference | October 7, 2024
  • American Society of Health System Pharmacists | Fluid Shortages – Suggestions for Management and Conservation | October 4, 2024
  • Healthcare Ready | Situation Overview | October 3, 2024
  • Baxter | Product Allocation Letter | October 1, 2024
  • American Society of Health System Pharmacists | Guidelines on Managing Drug Product Shortages
  • Situational Updates

  • American Hospital Association | 8 of 10 Baxter manufacturing lines restarted | December 20, 2024
  • Baxter | Hurricane Helene Updates | Last updated December 19, 2024
  • American Hospital Association | Baxter restores additional IV solutions production lines | December 10, 2024
  • American Hospital Association | Shortage of Empty IV Bags Expected to Last Through March | December 4, 2024
  • American Hospital Association | Increased Allocations for Certain IV Products | December 2, 2024
  • Baxter | Expiration Dating Extension to 24 Months | November 8, 2024
  • Food & Drug Administration | Hurricane Helene: Baxter’s manufacturing recovery in North Carolina | Last updated November 8, 2024
  • American Hospital Association | Updates on IV Fluid Supplies After Helene Forces Closure of Baxter Manufacturing Plant | Last updated October, 28, 2024
  • Healthcare Ready | 2024 Baxter Plant Alert Hub | September 30, 2024
  • Healthcare Ready | 2024 Hurricane Helene Alert Hub | September 25, 2024
  • United Through Crisis

    Crisis has a way of reminding us of our commonalities.  

    Take, for instance, Hurricane Helene. Though California is far from the storm’s devastation, its effects have rippled all the way to our coast due to the temporary closure of Baxter International’s North Carolina plant, which supplies 60% of the nation’s IV fluids. Hospitals across the country are working to ensure continued patient care despite a shortage of supplies critical to emergency care, trauma, oncology, surgery, and other lifesaving services.  

    CHA Responds to Nationwide IV Fluid Shortage

    What’s happening: On Oct. 3, CHA informed members of an IV fluid shortage due to the temporary closure of Baxter International’s North Carolina plant, which supplies 60% of the country’s IV solutions. The facility was damaged by flooding from Hurricane Helene.   

    What else to know: The update from CHA includes guidance for hospitals to mitigate the impact of the IV shortage.  

    Johnson & Johnson Halts Proposed 340B Rebate Model

    What’s happening: Johnson & Johnson will stop its plan that would have required hospitals participating in the 340B drug discount program to purchase Stelara and Xarelto at full price and apply for a rebate instead of receiving full discounts upfront.  

    What else to know: The Health Resources and Services Administration (HRSA) notified J&J it would be kicked out of the 340B Drug Pricing Program if it did not halt implementation.  

    CHPSO’s October Webinars Address Three Critical Issues in Health Care

    What’s happening: This month, the Collaborative Healthcare Patient Safety Organization (CHPSO) is hosting three separate webinars that address patient safety, health care professional suicide, and maternal sepsis.  

    What else to know: Each webinar is designed to equip health care professionals with the latest research, practical solutions, and tools for improving patient outcomes and supporting clinician well-being — and CHA/CHPSO members who attend may earn continuing education credits with the California Board of Registered Nursing. 

    Ask Reps. to Sign Letter Opposing 340B Program Changes

    What’s happening: A bipartisan group of U.S. representatives is leading a letter to U.S. Health and Human Services (HHS) Secretary Xavier Becerra about efforts by Johnson & Johnson (J&J) to undermine the 340B Drug Discount Program.   

    What else to know: Hospital leaders should call or email their U.S. representative and urge them to sign on to the letter by Sept. 27.  

    CMS Requests Information on AI Use in Health Care

    What’s happening: The Centers for Medicare & Medicaid Services (CMS) issued a request for information (RFI) on how artificial intelligence (AI) is used to improve health care delivery, with the goal of informing future rulemaking. 

    What else to know: CMS will select organizations to showcase their AI products and services to educate the agency and inform future policymaking during a series of “Demo Days” starting in October.